Sutro Biopharma (STRO) Announces Proposed Public Offering of 5 Million Shares of Common Stock

Go back to Sutro Biopharma (STRO) Announces Proposed Public Offering of 5 Million Shares of Common Stock

Sutro Biopharma Inc. (STRO) Prices 6M Share Common Offering at $21/Sh

December 9, 2020 6:10 AM EST

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and autoimmune therapeutics, today announced the pricing of an underwritten public offering of 6,000,000 shares of its common stock at a price to the public of $21.00 per share. The gross proceeds... More